Other Headlines

Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.
The medical community pays tribute to a dedicated crew.
Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.
The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.
GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

House Passes Medicare Physician Payment Reform Act Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.

Clinical PET-MRI Moves Closer to Reality Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Scientists Find Unusual Immune System Activity in Brains of Schizophrenics The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Aural Trumps Oral for Ear Treatment A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.

Senate Health Care Reform Bill Unveiled Legislation may go to cloture vote this weekend. Read the details.

RSNA 2009 Preview This year's RSNA should provide a very interesting look at the effects of the economy on the major OEMs. As always, vendors are whipping up the hoopla, and inside this story are great previews of what's being debuted. But DOTmed reporters will also be there to get the real buzz. Look for video interviews in our Online News direct from the show.

Interview With Fred Robertson, President & CEO of TomoTherapy TomoTherapy president and CEO Fred Robertson talks with DOTmed about his perspective on ASTRO's 2009 annual meeting, changes in the radiation oncology industry and two important TomoTherapy product launches that occurred at the show. Watch the HD video.

Pen-Sized Microscope Aims for Precise Brain Surgeries A confocal microscope picking up brain-safe fluorescent dyes could result in more accurate and streamlined surgeries to remove tumors from the brain.

Health Care Reform Round-Up: CBO Pegs Senate Bill at $849 Billion The numbers are in on the Senate's version of reform. Also read about the wide-ranging impact that the legislation would have.

U.S. Preventive Services Task Force Has Stunning New Guidelines on Mammography Agency recommends no routine screening for women 40-49, no self-examination. Read the details.

Warning list available

FDA Issues Warning List of Heparin Products

by Joan Trombetti, Writer
Over the past year, Heparin, a widely used injectable anticoagulant, has come under intense scrutiny from consumer protection groups and the Food and Drug Administration.

In December 2007, the FDA recalled a shipment of heparin because of a growth of Serratia marcescens in several unopened syringes of this product. Serratia marcescens is a bacterium that can lead to life-threatening injuries and/or death.

Only six months ago, major recalls of heparin were announced by the FDA due to contamination of the raw heparin stock imported from China. The FDA released a statement that revealed the contaminated heparin killed at least 81 people in the U.S.

The most high-profile instance of negligent heparin overdose occurred in November 2007, when actor Dennis Quaid's twelve-day-old twins were accidentally given an adult dosage of the drug (the adult dosage was 1,000 times the recommended dosage for infants). The Quaid family subsequently sued the manufacturer of the product, Baxter Healthcare Corp., for over $50,000 for allegedly confusing labeling and design that made the adult and infant versions of the product difficult to differentiate.

And, just this past summer, in July, another set of twins born at a Texas hospital died after an accidentally administered overdose of the drug.

Thus, the FDA updated its heparin recall list to include medical devices and diagnostic products that may contain or be coated with heparin. The FDA does not mean to suggest that all of the products herein have been or are affected by contaminated heparin, but its purpose is to warn consumers of potential products and devices that could be life-threatening if they contain contaminated heparin.

Also, as several other cases arose of people falling ill or dying due to products that contained or were coated with contaminated heparin (i.e another instance that involved Baxter International and one of its suppliers, a company that spun off from Oscar Meyer; the connection: pigs naturally produce proteins used in pharmaceuticals.), the FDA felt it was necessary to include companies that have otherwise yet to receive a complaint or have been forced to recall their products, due to the diversity in suppliers of heparin and its widespread usage. To see the FDA list warning consumers go to: http://losangeles.injuryboard.com/fda-and-prescription- drugs/fda-warning-list-of-medical-devices-diagnostic- products-that-may-contain-heparin.aspx?goggleid=252166

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED